Ipca Laboratories Sustainability Profile
Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management. With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.
DitchCarbon Score
How does Ipca Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ipca Laboratories's score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ipca Laboratories's reported carbon emissions
In 2025, Ipca Laboratories reported total carbon emissions of approximately 582,391,000 kg CO2e, comprising 169,992,000 kg CO2e from Scope 1, 124,512,000 kg CO2e from Scope 2, and 287,887,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, with disclosures across all three scopes. For the year 2024, the company recorded emissions of about 618,543,000 kg CO2e, with Scope 1 emissions at 174,538,000 kg CO2e, Scope 2 at 137,345,000 kg CO2e, and Scope 3 at 306,660,000 kg CO2e. In 2023, total emissions were approximately 304,994,000 kg CO2e, with Scope 1 at 124,880,000 kg CO2e and Scope 2 at 179,114,000 kg CO2e. Ipca Laboratories has set ambitious climate commitments, aiming for a 20% reduction in carbon emissions from both Scope 1 and Scope 2 by 2030, with 2022 as the base year. This commitment is part of their broader strategy to enhance sustainability within the pharmaceutical sector. Additionally, the company is committed to achieving net-zero emissions, demonstrating a proactive stance towards climate action. The emissions data and reduction targets are sourced directly from Ipca Laboratories, with no cascading from a parent or related organization. The company is actively engaged in monitoring and reporting its carbon footprint, aligning with industry standards for transparency and accountability in climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | 51,938,620 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 598,518,280 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 6,451,465,560 | - | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Ipca Laboratories's Industry?
How Carbon Intensive is Ipca Laboratories's Location?
Ipca Laboratories's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ipca Laboratories has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Akums Drugs and Pharmaceuticals Limited
Frequently Asked Questions
Common questions about Ipca Laboratories's sustainability data and climate commitments